At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
oxyhydrogen generator (AMS-H-03) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Hydrogen Gas Immunotherapy Promotes the Rehabilitation and Prognosis of Cancer Patients After Standard Treatments
In Brief
A clinical study evaluating oxyhydrogen generator (AMS-H-03) and analogue machine for Adult Solid Tumor. Completed, enrolled 30 participants across 1 site.
Detailed Summary
The aim of this study is the efficacy of hydrogen gas immunotherapy to rehabilitation and prognosis of cancer patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAdult Solid Tumor
CountriesChina
CollaboratorsShanghai Asclepius Meditech Co., Ltd
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartJun 2018
First PostedJan 2019
Primary CompletionJun 2020
Study CompletionAug 2020
TodayJul 2026
First PostedJan 28, 2019
Enrollment StartJun 2, 2018
Primary CompletionJun 20, 2020
Study CompletionAug 20, 2020
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 7.4 years ago
Interventions
oxyhydrogen generator (AMS-H-03)device
Rated gas output (L) : 3L/min, concentration of hydrogen and the oxygen was 66.6% and 33.3%, respectively. The patients inhale 3 hours each day through a cannula or mask, and persist for long term
analogue machinedevice
This machine has the same apperance and gas condition